Beta-Aminoisobutyric Acid Inhibits Hypothalamic Inflammation by Reversing Microglia Activation

Cells. 2019 Dec 11;8(12):1609. doi: 10.3390/cells8121609.

Abstract

Beta-aminoisobutyric acid (BAIBA), a natural thymine catabolite, is involved in the beneficial effects of exercise on metabolic disorders. In particular, it has been reported to reverse the inflammatory processes observed in the peripheral organs of animal models of obesity. Therefore, this study aimed to investigate whether BAIBA improves hypothalamic inflammation, which is also tightly coupled with the development of obesity. We observed that treatment with BAIBA effectively reversed palmitic acid-induced hypothalamic inflammation and microglial activation in vivo. Consistent with these findings, we confirmed that BAIBA reversed body weight gain and increased adiposity observed in mice fed with a high-fat diet. Collectively, the current findings evidence the beneficial impacts of BAIBA on the imbalance of energy metabolism linked to hypothalamic inflammation.

Keywords: beta-aminoisobutyric acid; hypothalamus; inflammation; microglia; myokine; obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoisobutyric Acids / administration & dosage*
  • Aminoisobutyric Acids / pharmacology
  • Animals
  • Cell Line
  • Cytokines / genetics
  • Cytokines / immunology
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Encephalitis / chemically induced
  • Encephalitis / drug therapy*
  • Encephalitis / immunology
  • Energy Metabolism / drug effects
  • Humans
  • Hypothalamus / drug effects*
  • Hypothalamus / immunology
  • Male
  • Mice
  • Microglia / drug effects
  • Microglia / immunology*
  • Obesity / chemically induced
  • Obesity / complications
  • Obesity / drug therapy*
  • Palmitic Acid / adverse effects*

Substances

  • Aminoisobutyric Acids
  • Cytokines
  • Palmitic Acid
  • 3-aminoisobutyric acid